Comparison of peripheral nerve damages according to glucose control timing in experimental diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 8, 2012, Pages 451-459

  Jin, H Y ^a   Kang, S M ^b   Liu, W Y ^a   Song, C H ^a   Lee, K A ^a   Baek, H S ^a   Park, T S ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

diabetic peripheral neuropathy; intraepidermal nerve fiber density; timing of glucose control

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; FOOD INTAKE; HYPERGLYCEMIA; MALE; MYELIN SHEATH; MYELINATED NERVE; NERVE FIBER; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; EPIDERMIS; GASTRIC MUCOSA; HEMOGLOBIN A, GLYCOSYLATED; HYPERGLYCEMIA; INSULIN; KIDNEY CORTEX; MALE; NERVE FIBERS, MYELINATED; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UBIQUITIN THIOLESTERASE;

EID: 84866403292     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1306350     Document Type: Article

References (23)

1. Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol: 2008; 45 1 16
2. Ceriello A. Hypothesis: the "metabolic memoryo", the new challenge of diabetes. Diabetes Res Clin Pract: 2009; 86 01 S2 S6
3. Ceriello A, Ihnat M A, Thorpe J E. Clinical review 2: The "metabolic memoryo": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab: 2009; 94 410 415
4. Chew E, Ambrosius W, Davis M et al. Effects of medical therapies on retinopathy progresion in type 2 diabetes. The New England journal of medicine: 2010; 363 233 244
5. Duckworth W, Abraira C, Moritz T et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. New England Journal of Medicine: 2009; 360 129 139
6. Edwards J L, Vincent A M, Cheng H T et al. Diabetic neuropathy: mechanisms to management. Pharmacol Ther: 2008; 120 1 34
7. Fard A S, Esmaelzadeh M, Larijani B. Assessment and treatment of diabetic foot ulcer. International journal of clinical practice: 2007; 61 1931 1938
8. Gerstein H C, Riddle M C, Kendall D M et al. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol: 2007; 99 34i 43i
9. Gimbel J, Richards P, Portenoy R. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology: 2003; 60 927 934
10. Holman R R, Paul S K, Bethel M A et al. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. New England Journal of Medicine: 2008; 359 1577 1589
11. Jin H Y, Liu W J, Park J H et al. Effect of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor (Vildagliptin) on Peripheral Nerves in Streptozotocin-induced Diabetic Rats. Archives of Medical Research: 2009; 40 536 544
12. Jin H Y, Lee K A, Song S K et al. Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats. Eur J Pharmacol: 2012; 674 217 226
13. Kowluru R A. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes: 2003; 52 818 823
14. Max M B, Lynch S A, Muir J et al. Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy. New England Journal of Medicine: 1992; 326 1250 1256
15. Partanen J, Niskanen L, Lehtinen J et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. The New England journal of medicine: 1995; 333 89 94
16. Patel A. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. The Lancet: 2007; 370 829 840
17. Perkins B A, Greene D A, Bril V. Glycemic Control Is Related to the Morphological Severity of Diabetic Sensorimotor Polyneuropathy. Diabetes Care: 2001; 24 748 752
18. Raskin J, Smith T, Wong K et al. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. Journal of palliative medicine: 2006; 9 29 40
19. Richter R, Portenoy R, Sharma U et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. The journal of pain: 2005; 6 253 260
20. Vinik A I. Advances in diabetes for the millennium: new treatments for diabetic neuropathies. MedGenMed: 2004; 6 13
21. Vinik A I, Mehrabyan A. Diabetic neuropathies. Med Clin North Am: 2004; 88 947 999 xi
22. Yagihashi S, Yamagishi S-I, Wada R. Pathology and pathogenetic mechanisms of diabetic neuropathy: Correlation with clinical signs and symptoms. Diabetes Research and Clinical Practice: 2007; 77 S184 S189
23. Zor T, Selinger Z. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Analytical biochemistry: 1996; 236 302 308